Have £5k to invest in UK stocks? Here are my top 3 FTSE 100 shares for May

If you have spare cash available to invest in UK stocks, shares in these top FTSE 100 companies could be a strong buy in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re looking to invest £5k in the stock market crash, now could be an ideal opportunity to do so. A fresh sell-off in early May has once again sent the share prices of some top FTSE 100 stocks plunging. 

At the moment, a handful of these look like strong buys to me. Provided investors hold for the long term, I think they offer the prospect of attractive returns and sizeable dividend payouts. So, here’s my selection of top FTSE 100 shares for the month of May.

GlaxoSmithKline

Multinational pharmaceutical company GlaxoSmithKline (LSE: GSK) is on the frontline in the battle against Covid-19. The company recently announced it has joined forces with French healthcare giant Sanofi in the race to create a vaccine.

Whether successful or not, GSK looks well-set to deliver a strong performance this year. First-quarter results were impressive, with group sales rising by 19% to £9.1bn. This was driven by growth across all three of the company’s divisions, with a particularly strong showing from vaccines.

Despite this, GSK’s price-to-earnings ratio sits at a modest 13. For me, this suggests there’s value to be had as I expect high earnings and growth to continue in 2020. For that reason, I think the 4.8% yielding stock is a solid buy this May.

British American Tobacco

Making the jump from medicine to cigarettes, tobacco manufacturing company British American Tobacco (LSE: BATS) is another top FTSE 100 share in my eyes.

The so-called ‘sin stock’ boasts an eye-watering yield of around 7% and has recently pledged to stick to its dividend policy. What’s more, largely thanks to a limited impact on consumer demand, the tobacco company predicts solid earnings growth for 2020.

In line with its target, the FTSE 100 firm forecasts high single figure earnings growth in 2020. This is supplemented by an already strong start to the year, where the company saw its market share rise by 0.2%.

In my view, British American Tobacco’s pledge to stick to its dividend policy is testament to the strength of the company’s financial position. Especially when almost a third of other FTSE 100 companies are cutting or scrapping payments.

A comparatively low price-to-earnings ratio of 9 only sweetens the deal in my eyes. Moreover, steady consumer demand for its products means this company won’t be going anywhere anytime soon.

Reckitt Benckiser

Consumer goods company Reckitt Benckiser (LSE: RB) has seen its share price bounce back from a 20% plunge in the depths of the market crash to now sit 6% up on the start of the year. I think it’s clear to see why.

Last week, the company raised its full-year outlook after it reported a 12.3% rise in first-quarter sales. The impressive results were driven by an increase in demand for the firm’s hygiene products, which include Dettol, Vanish, and Nurofen.

However, with a price-to-earnings ratio of 18, shares don’t come cheap. That said, my expectations of a bumper performance in 2020, driven by unwavering consumer demand, leads me to believe the figure is justified.

All in all, I think these top FTSE 100 stocks are worthy long-term investments. In my view, investors with spare cash to spend could be well-set to profit in the long run from holding shares in each of these companies as they grow their earnings and consolidate their respective market positions.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Matthew Dumigan has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »

Investing Articles

After gaining over 200% in 12 months, what’s next for Nvidia stock?

Oliver thinks Nvidia stock could be as enduring an investment as Amazon. Even given the valuation risks, he says he…

Read more »